✦ LIBER ✦

CLinical experience acquired with the efalizumab (Raptiva®) (CLEAR) trial in patients with moderate-to-severe plaque psoriasis: results from a phase III international randomized, placebo-controlled trial

✍ Scribed by L. Dubertret; W. Sterry; J.D. Bos; S. Chimenti; S. Shumack; C.G. Larsen; N.H. Shear; K.A. Papp; CLEAR Multinational Study Group

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical Efficacy of Efalizumab in Patie

✍ David M. Pariser; Kenneth B. Gordon; Kim A. Papp; Craig L. Leonardi; Paul Kwon; 📂 Article 📅 2005 🏛 Springer-Verlag 🌐 English ⚖ 201 KB

Adalimumab in Japanese patients with mod

✍ Akihiko ASAHINA; Hidemi NAKAGAWA; Takafumi ETOH; Mamitaro OHTSUKI; THE ADALIMUMA 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 490 KB

Impact of adalimumab treatment on health

✍ D. Revicki; M.K. Willian; J.-H. Saurat; K.A. Papp; J.-P. Ortonne; C. Sexton; A. 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 195 KB